Remotely-supervised Transcranial Direct Current Stimulation (tDCS) for At-home Treatment of Fatigue and Cognitive Slowing in Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

May 1, 2020

Study Completion Date

May 1, 2020

Conditions
Parkinson Disease
Interventions
DEVICE

Active tDCS

low amplitude direct currents to induce changes in cortical excitability. tDCS produces current intensities in the brain orders of magnitude below other stimulation techniques such as transcranial magnetic stimulation (TMS) or electroconvulsive therapy (ECT)

DEVICE

Sham tDCS

The device will be programmed to deliver either active or sham tDCS (all study personnel and participants will be blinded), and operated with unlock codes provided by the study technician daily to release one session

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT03189472 - Remotely-supervised Transcranial Direct Current Stimulation (tDCS) for At-home Treatment of Fatigue and Cognitive Slowing in Parkinson's Disease | Biotech Hunter | Biotech Hunter